Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

NCT00909558 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Glioma
Hepatocellular Cancer
Squamous Cell Lung Cancer
Pancreatic Cancer
Colon Cancer
Prostate Cancer

Interventions

BIOLOGICAL: Autologous Natural Killer / Natural Killer T Cell Immunotherapy

Sponsor

Envita Medical Center, Inc.